Published by Josh White on 4th May 2020
(Sharecast News) - Clinical-stage biotechnology company ValiRx announced a conditional fundraise through the conditional issue of 18,069,467 new ordinary shares on Monday, to raise ?1.17m.
URL: http://www.digitallook.com/dl/news/story/30616083/...